Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Lucid Diagnostics announces proposed public stock offering
-
Lucid Diagnostics announces proposed public stock offering
-
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
Lucid Diagnostics (LUCD) Announces Closing of Public Offering of Common Stock
-
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
-
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
-
Lucid Diagnostics (LUCD) Announces Proposed Public Offering of Common Stock
-
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
-
Lucid Diagnostics Inc (LUCD) Closes $15.3M Direct Offering
-
Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
-
Lucid Diagnostics Inc (LUCD) Prices 13.94M Share Offering at $1.10/sh
-
Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
-
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum
-
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference
-
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
-
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics (LUCD) IPO Opens, Trades Lower
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
PAVmed's (PAVM) Lucid Diagnostics Files For a Proposed IPO
-
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
-
PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
-
PAVmed to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

